Tag: Pharma
Innate Pharma: profit down, but cash flow ‘solid’
(CercleFinance.com) – Innate Pharma announced on Thursday a drop in its profit over the first six months of the year, the biotechnology company having suffered from the decline in revenues…
World Sepsis Day: ABIONYX Pharma confirms its commitment against sepsis, a global public health issue – 09/12/2023 at 8:00 p.m.
• Sepsis, 3rd cause of death in the world, worsened by the spread of bacterial infections with global warming and by the aging of the population • No effective therapeutic…
Maat Pharma: 35.1 million euros in cash, visibility until the 2nd quarter of 2024 – 09/07/2023 at 10:10
(AOF) – Maat Pharma announces that as of June 30, 2023, its cash and cash equivalent position amounted to 35.1 million euros, for a second quarter turnover of 0.7 million…
Maat Pharma: MaaT033 declared an orphan drug by the EMA – 09/07/2023 at 2:26 p.m.
(AOF) – Maat Pharma announces that its drug MaaT033 (capsule), currently developed as an adjuvant treatment to improve the overall survival of patients who have received a hematopoietic stem cell…
Jefferies picks up Nanobiotix to ‘buy’ as JNJ deal delivers ‘big pharma muscle’ – 08/25/2023 at 10:20 am
(Photo credits: Nanobiotix – ) **Jefferies resumes Nanobiotix NANOB.PA coverage with a buy note, citing the benefits of the biotech company’s partnership with Johnson & Johnson’s (JNJ) Janssen for experimental…
ABIONYX Pharma provides an update on its activity and its cash position for the 1st half of 2023 – 08/17/2023 at 6:00 pm
Cash of €1.9 million (excluding CIR) as of June 30, 2023 Toulouse, FRANCE, Lakeland, USA, August 17, 2023, 5:45 p.m. – ABIONYX Pharma (FR0012616852 – ABNX), a next-generation biotech company…
Abionyx Pharma: 1.9 million euros in cash in the first half – 08/17/2023 at 6:21 pm
(AOF) – Abionyx Pharma, a new generation biotech dedicated to the discovery and development of innovative therapies, recorded consolidated half-year sales of 2.1 million euros, after elimination of intra-group transactions.…
Abionyx Pharma: 1.9 million euros in cash in the first half – 08/17/2023 at 6:21 pm
(AOF) – Abionyx Pharma, a new generation biotech dedicated to the discovery and development of innovative therapies, recorded consolidated half-year sales of 2.1 million euros, after elimination of intra-group transactions.…
Abionyx Pharma: 1.9 million euros in cash in the first half
(AOF) – Abionyx Pharma, a new generation biotech dedicated to the discovery and development of innovative therapies, recorded consolidated half-year sales of 2.1 million euros, after elimination of intra-group transactions.…
In the United States, Big Pharma at the heart of the drug price storm
An activist with a sign “Be a Hero”, an organization in favor of controlling the price of drugs in the United States, in front of the Capitol, in Washington, on…
MaaT Pharma joins the Microbiome Therapeutics Innovation Group – 07/20/2023 at 18:23
MaaT Pharma (EURONEXT: MAAT – the “Company”), a late-stage biotechnology company, leader in the development of Microbiome Ecosystem TherapiesTM (MET) aimed at improving the survival of cancer patients, announces today…
Sanofi: Strategic collaboration with Recludix Pharma
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…